Education
Health
Dr. Tejinder Bhatti Completes 20 Years in Hair Restoration Surgery as Demand for Ethical Procedures Grows
New Delhi [India], June 12: India’s hair transplant sector has grown rapidly over the past two decades. Once a limited cosmetic treatment, it is now a mainstream medical procedure for a diverse range of patients. This growth has also increased focus on surgical ethics, physician involvement, and patient safety.
While many clinics shift toward large-scale commercial operations, Dr. Tejinder Bhatti, based in Mumbai and Mohali, marks 20 years in the field with a practice focused on direct surgeon-led care and controlled procedures.
Dr. Bhatti is recognized for prioritizing natural-looking results, long-term patient follow-up, and personally performing hair restoration procedures.
India Emerges as a Major Hair Transplant Destination
India is now a leading destination for hair transplant procedures, driven by affordable costs and increasing medical tourism. Patients worldwide travel to Indian cities for cosmetic and hair restoration surgeries.
However, experts note that rapid growth has raised concerns about quality control. Many clinics now use high-volume models where technicians perform procedures and surgeons oversee multiple patients at once.
Specialists emphasize that hair transplantation is a microsurgical procedure requiring careful donor planning, precise graft handling, and accurate implantation. Errors during surgery can cause permanent donor damage and unnatural results.
With increased patient awareness, more individuals now consider physician involvement and long-term treatment quality when choosing a clinic.
Darling Buds Clinic Builds Reputation for Personalized Care
Dr. Bhatti’s work is closely associated with Darling Buds Clinic in Mohali and Mumbai. The clinic is recognized for its personalized treatment approach, distinguishing it from high-volume cosmetic practices.
Patients and industry observers note that consultations at the clinic emphasize donor assessment, realistic expectations, and long-term planning before recommending surgery. Experts highlight the importance of this approach as more patients seek corrective procedures after unsuccessful transplants elsewhere.
The clinic also attracts international patients seeking doctor-led procedures and long-term follow-up, rather than package-based cosmetic treatments.
“One Patient, One Doctor” Model Gains Attention
Dr. Bhatti’s “One Patient. One Doctor. One Clinic” approach distinguishes his practice from many commercial operations.
Rather than performing multiple surgeries simultaneously, Dr. Bhatti remains personally involved throughout each transplant. Experts in aesthetic surgery note that doctor-performed procedures often improve consistency in graft placement, hairline planning, and density distribution.
Medical professionals note that hair transplantation is not only a technical procedure but also an aesthetic one. The direction, angle, and placement of every graft influence how natural the final result appears.
As cosmetic procedures become more common, many patients now prefer personalized treatment over production-style clinics.
Natural Hairline Design Becomes Priority
Modern hair transplant surgery now aims for results that blend seamlessly with existing hair and remain undetectable, rather than simply covering bald areas.
Hair restoration experts state that natural hairline design is now a critical aspect of the procedure. Poorly planned hairlines can look artificial and may not age well. Dr. Bhatti has gained recognition for conservative, realistic hairline planning that considers long-term facial balance.
Specialists say this approach is important because hair loss often persists with age, making donor management critical for future correction or additional treatment.
Patients now expect results that look natural both in person and on high-definition cameras, especially given the prevalence of social media and digital visibility.
DHX Technique Focuses on Precision and Graft Survival
Dr. Bhatti developed the DHX hair transplant technique, which emphasizes careful graft handling and implantation planning to improve post-transplant survival rates.
Hair restoration specialists note that graft survival is a key factor in final density and long-term success. Damage during extraction or implantation can reduce growth quality and impact appearances during surgery, allowing faster recovery and limited visible scarring.
Experts observe that recent advancements in hair transplantation focus on refinement and consistency rather than dramatic cosmetic changes.
Hospital-Based Procedures Add Safety Layer
Dr. Bhatti performs surgeries at 5 Rivers Hospital in Mohali, unlike many standalone cosmetic centres.
Medical professionals state that hospital infrastructure offers higher sterilization standards, better anaesthesia support, and improved emergency preparedness compared to smaller clinics.
Safety is now a major concern in India’s cosmetic surgery industry as more low-cost operators enter the market. Doctors report that informed patients increasingly evaluate clinics based on medical infrastructure and surgical accountability, not just price.
For international patients, hospital-based procedures offer added reassurance about treatment quality and post-operative support.
As the industry continues to grow, discussions around ethics, patient safety, and medically supervised treatment are expected to remain important.
Over the past 20 years, Dr. Tejinder Bhatti has become one of the most widely recognized names in hair restoration surgery, especially among patients seeking natural-looking results and doctor-led treatment supported by long-term follow-up care.
Disclaimer: This press release is for general information purposes only and should not be construed as professional medical advice. Always consult a doctor before taking any decisions.
Business
Unihealth Hospitals Announces Strategic Share Swap to Increase Stake in Uganda’s Victoria Hospital
Mumbai (Maharashtra) [India], June 16: Unihealth Hospitals Limited (NSE: UNIHEALTH | INE0PRF01011), an integrated healthcare services provider listed on NSE Emerge, today announced that it proposes to increase its stake in Victoria Hospital Limited (“Victoria Hospital”), a healthcare company incorporated in Uganda, through a strategic share-swap arrangement with the existing shareholders of Victoria Hospital.
Unihealth presently holds 50% equity in Victoria Hospital Limited, with the remaining 50% being held by its partners based in Uganda. Under the proposed transaction, Unihealth intends to acquire additional ordinary shares of Victoria Hospital Limited from its partners by issuing equity shares of Unihealth to them.
The transaction shall be undertaken through a share exchange mechanism wherein the sellers will transfer their equity shares in Victoria Hospital Limited to Unihealth and, in consideration thereof, Unihealth shall issue its equity shares to the sellers. The share exchange ratio and the number of equity shares to be issued shall be determined based on independent valuation reports and shall be subject to applicable regulatory approvals and customary closing conditions.
Strategic Rationale of the Transaction
The proposed acquisition represents an important milestone in Unihealth’s strategy of building an integrated healthcare delivery platform across emerging markets, with a focus on Africa as a high-growth healthcare opportunity.
Victoria Hospital Limited is a strategically important healthcare asset in Uganda and has demonstrated strong operational performance, financial growth and profitability. The proposed increase in ownership will enable Unihealth to further align strategic objectives, enhance operational integration and participate more significantly in the future growth potential of the hospital.
Victoria Hospital Limited has delivered robust financial performance during FY 2025-26, reflecting strong demand for quality healthcare services and operational efficiencies. During FY 2025-26, Revenue increased to ₹114.47 cr., compared to ₹ 85.99 cr. in the previous year, representing strong year-on-year growth. Its profit after tax (PAT) increased to ₹43.63 cr., compared to ₹25.81 in the previous year.
The proposed increase in ownership of Victoria Hospital Limited is expected to provide several strategic and financial benefits to Unihealth. Once completed, this transaction will allow enhancement of consolidated profitability for the Company attributable to its equity shareholders. The transaction is expected to support improved earnings visibility, enhanced operating leverage and greater participation in future expansion opportunities.
The proposed transaction structure allows Unihealth to increase its strategic ownership without immediate deployment of substantial cash resources. The share-swap mechanism enables preservation of liquidity, continued investment in growth initiatives and alignment of interests between Unihealth and the Selling Shareholders.
The transaction supports Unihealth’s long-term objective of developing a scalable healthcare platform across Africa by combining established hospital infrastructure, clinical expertise, healthcare management capabilities and regional market knowledge and positions Unihealth to capitalise on increasing healthcare demand in emerging markets.
Victoria Hospital Limited, operating under the UMC Victoria Hospital brand in Kampala, Uganda, has established itself as a leading tertiary care centre offering a comprehensive range of specialized and super-specialty healthcare services. The hospital is recognized for its advanced capabilities in Spine, Orthopaedics & Joint Replacement, Oncology, Nephrology & Dialysis, Gastroenterology, Cardiology & Cardiac Care, Critical Care, Internal Medicine, General & Laparoscopic Surgery, Obstetrics & Gynaecology, IVF, Paediatrics and advanced Diagnostic Services. As part of its continued commitment to bringing world-class healthcare technology to East Africa, the hospital is also in the process of introducing advanced ophthalmology and neurosurgical equipment to develop Eye Care and Neurosciences services in the coming months, further strengthening its position as a regional centre of excellence for complex and specialized medical care. The Company recently commissioned its 30-bedded facility in Entebbe and intends to expand its network of clinics and secondary care facilities across the country in the coming 12 months, increasing its footprint and consolidating its position as a premier healthcare provider in Uganda.
| Top of Form Commenting on the proposed transaction, Dr. Akshay Parmar, Founder and Managing Director of UniHealth Hospitals Limited said, “Unihealth has always focused on creating sustainable healthcare platforms in high-growth markets. Increasing our stake in Victoria Hospital Limited is a strategic step towards strengthening our international healthcare presence and consolidating our position in Uganda. Victoria Hospital has demonstrated strong operational performance, with significant growth in revenue, profitability and net assets. This transaction will enable Unihealth to participate more meaningfully in the future growth of this healthcare asset while maintaining financial discipline through a share-swap structure. We remain committed to delivering quality healthcare services and creating long-term value for our patients, employees, stakeholders and shareholders.”Bottom of Form |
Unihealth Hospitals Limited
Founded in Mumbai in 2010, Unihealth Hospitals Limited is an integrated healthcare platform focused on delivering affordable, accessible, and high-quality healthcare services across India and East Africa. The Company operates across multiple healthcare verticals, including hospital operations, healthcare consultancy, pharmaceutical and consumables exports, and medical value travel.
Through the Unihealth–UMC Hospitals network, the Company combines Indian clinical expertise, global healthcare standards, and localized partnerships to create a scalable healthcare ecosystem serving diverse patient populations across emerging markets.
Driven by its mission of “Healthcare for All,” Unihealth continues to expand its healthcare footprint while creating long-term value for patients, communities, healthcare professionals, and shareholders.
The Company was listed on NSE Emerge in September 2023.
For FY26, the Company reported consolidated Total Income of ₹137.01 Cr, EBITDA of ₹58.82 Cr, and Net Profit attributable to the equity shareholders of the Company of ₹25.83 Cr.
If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.